A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions

PainNauseaVomiting

Interventions

DRUG

CL-108

7.5 mg/325 mg/12.5 mg tablet

DRUG

M366

7.5 mg/325 mg tablet

DRUG

Placebo